Protagenic Therapeutics, Inc. (PTIXW)
- Previous Close
0.0025 - Open
0.0025 - Bid --
- Ask --
- Day's Range
0.0025 - 0.0025 - 52 Week Range
0.0025 - 0.0025 - Volume
160 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.35
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
www.protagenic.comRecent News: PTIXW
View More
Compare To: PTIXW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PTIXW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-113.49%
Return on Equity (ttm)
-236.06%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-5.53M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
1.84M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.2M